Beryllium Exposure Surveillance (BeLPT)

This contract involves providing specialized medical services focused on the screening and monitoring of employees who may be exposed to beryllium, a hazardous material known to cause chronic health issues. The key service required is performing blood work, specifically Beryllium Lymphocyte Proliferation Testing (BeLPT), alongside ongoing medical surveillance to detect and manage beryllium sensitization or disease. The contract aims to ensure workplace health and safety by facilitating early diagnosis and intervention for affected personnel. Issued by the CDC Office of Acquisition Services under the Department of Health and Human Services, this opportunity is a subcontract designated as a Total Small Business Set-Aside under the SBA, following FAR 19.5 guidelines. The solicitation was posted in late May 2026, with responses due by early June 2026. The work will be performed in Morgantown, with a NAICS code of 621511, indicating specialized outpatient diagnostic and treatment services. This contract underscores the commitment to occupational health compliance and worker protection in facilities where beryllium exposure is a risk.